Discontinued Operations (Tables)

6 Months Ended

Mar. 31, 2013

Operating Results from Discontinued Operations

The following is a summary of the operating results of SurModics Pharmaceuticals discontinued operations for the three and six months ended March 31, 2013 and 2012 (in thousands):

	Three months ended						Six months ended
	March 31,						March 31,
	2013			2012			2013			2012
Total revenue	$	—		$	—		$	—		$	5,311
Income (loss) from discontinued operations	$	1,015		$	(221	)	$	1,015		$	2,309
Income tax provision		(333	)		(123	)		(333	)		(1,048	)
Income (loss) from discontinued operations, net of income taxes	$	682		$	(344	)	$	682		$	1,261
Income (loss) on sale of discontinued operations	$	—		$	26		$	—		$	(1,634	)
Income tax benefit		—			95			—			701
Income (loss) on sale of discontinued operations, net of income taxes	$	—		$	121		$	—		$	(933	)

Assets and Liabilities of Discontinued Operations

The major classes of assets and liabilities of discontinued operations as of March 31, 2013 and September 30, 2012 were as follows (in thousands):

	March 31,		September 30,
	2013		2012
Accounts receivable, net	$	—	$	283
Other current assets		129		600
Current assets of discontinued operations		129		883
Total assets of discontinued operations	$	129	$	883
Other current liabilities payable	$	271	$	1,640
Current liabilities of discontinued operations		271		1,640
Total liabilities of discontinued operations	$	271	$	1,640